TTP-4000

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameTTP-4000
Drug Alias NameTTP-4000
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionAdvanced glycosylation end product-specific receptor antagonists
TargetsAdvanced glycosylation end product-specific receptor
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVtv Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVtv TherapeuticsPfizer Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A